EUVIMEDEUVIMED entdecken
Crossref

Epitope‐Imprinted Polymer Nanoparticles Enable Selective Recognition of Filamentous Vimentin for Tumor Imaging In Vivo

Kamaran Khurshid Dar, Yuan Li iD, Yongqin Lv iD

Advanced Healthcare Materials · 2026-11 · 15 (41)

DOI: 10.1002/adhm.71813 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 06.10.2026. Verfasst von Kamaran Khurshid Dar und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical Technology, Beijing, China. Hauptthemen laut MEDLINE: Vimentin, Nanoparticles, Epitopes, Molecular Imprinting. Die Arbeit nennt 63 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing-Tianjin-Hebei Natural Science Foundation Cooperation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vimentin is a cytoskeletal protein upregulated during epithelial‐mesenchymal transition that can also be aberrantly displayed on the surface of multiple tumor cell types, making it a promising target for tumor imaging. Here, we develop epitope‐imprinted polymer nanoparticles (nanoMIPs) for vimentin recognition through a two‐step strategy comprising screening a library of non‐imprinted nanoparticles to identify a lead formulation, followed by peptide‐directed molecular imprinting. The resulting nanoMIPs exhibited enhanced apparent affinity for vimentin, with picomolar‐range K D values, although these values represent model‐dependent ensemble apparent affinities that may include contributions from multiple nanoparticle‐ligand contacts and local rebinding rather than intrinsic monovalent affinities. The nanoMIPs preferentially bound cancer cells presenting cell‐surface vimentin in vitro. The enhanced target binding and reduced off‐target binding were consistent with an imprinting‐associated improvement in molecular discrimination, although nonspecific physicochemical interactions were not completely eliminated. These findings extend epitope‐guided nanoMIP design to structurally dynamic, cell surface‐associated cytoskeletal targets, and support the development of synthetic receptors for tumor imaging. In vivo, the optimized nanoMIPs produced a tumor‐associated fluorescence signal approximately 1.44 times that of the matched non‐imprinted nanoparticles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VimentinNanoparticlesEpitopesMolecular ImprintingPolymersNeoplasmsAnimalsHumansCell Line, TumorMiceMice, Nude

Stichwörter der Autor:innen

epitope imprintingmolecular recognitionmolecularly imprinted polymer nanoparticlestumor imagingvimentin

Substanzen

VimentinEpitopesPolymers

Autor:innen und Institutionen

  • State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical Technology, Beijing, China.
  • National Energy R&D Center for Biorefinery, International Joint Bioenergy Laboratory of Ministry of Education, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

ORCID-Profile: Yuan Li, Yongqin Lv

Förderung

  • National Natural Science Foundation of China
  • Beijing-Tianjin-Hebei Natural Science Foundation Cooperation Project

Zitieren

APA

Dar, K. K., Li, Y., & Lv, Y. (2026). Epitope‐Imprinted Polymer Nanoparticles Enable Selective Recognition of Filamentous Vimentin for Tumor Imaging In Vivo. Advanced Healthcare Materials, 15(41). https://doi.org/10.1002/adhm.71813

Vancouver

Dar KK, Li Y, Lv Y. Epitope‐Imprinted Polymer Nanoparticles Enable Selective Recognition of Filamentous Vimentin for Tumor Imaging In Vivo. Advanced Healthcare Materials. 2026;15(41). doi:10.1002/adhm.71813

BibTeX
@article{Dar2026,
  author = {Dar, Kamaran Khurshid and Li, Yuan and Lv, Yongqin},
  title = {Epitope‐Imprinted Polymer Nanoparticles Enable Selective Recognition of Filamentous Vimentin for Tumor Imaging In Vivo},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {41},
  doi = {10.1002/adhm.71813}
}
Kostenlos starten →